Citations

Showing 10 of 108152 citations.

Impact of Pharmacologically Left Shifting the Oxygen–Hemoglobin Dissociation Curve on Arterial Blood Gases and Pulmonary Gas Exchange During Maximal Exercise in Hypoxia
Stewart, Glenn M. , Cross, Troy J. , Joyner, Michael J. , Chase, Steven C. , Lehrer‐Graiwer, Josh, Dufu, Kobina , Vlahakis, Nicholas E., Johnson, Bruce D. , Curry, Timothy, Cross, Troy James , Joyner, Michael J , Curry, Timothy B.

Mayo Clinic

High Altitude Medicine & Biology | June 21, 2021 | Volume: 22 | Issue: 3 | Pages: 249-262

10.1089/ham.2020.0159 | PMID 34152867 Get It

Stewart, Glenn M., Troy J. Cross, Michael J. Joyner, Steven C. Chase, Timothy Curry, Josh Lehrer-Graiwer, Kobina Dufu, Nicholas E. Vlahakis, and Bruce D. Johnson. Impact of pharmacologically left shifting the oxygen–hemoglobin dissociation curve on arterial blood gases and pulmonary gas exchange during maximal exercise in hypoxia. High Alt Med Biol . 22:249–262, 2021. Introduction: Physiological and pathological conditions, which reduce the loading of oxygen onto hemoglobin (Hb), can impair exercise capacity and cause debilitating symptoms. Accordingly, this study examined the impact of pharmacologically left shifting the oxygen–hemoglobin dissociation curve (ODC) on arterial oxygen saturation (SaO 2 ) and exercise capacity. Methods: Eight healthy subjects completed a maximal incremental exercise test in hypoxia (F I O 2 : 0.125) and normoxia (F I O 2 : 0.21) before (Day 1) and after (Day 15) daily ingestion of 900 mg of voxelotor (an oxygen/Hb affinity modulator). Pulmonary gas exchange and arterial blood gases were assessed throughout exercise and at peak. Data for a 1,500 mg daily drug dose are reported in a limited cohort ( n = 3). Results: Fourteen days of drug administration left shifted the ODC (p50 measured under standard conditions, Day 1: 28.0 ± 2.1 mmHg vs. Day 15: 26.1 ± 1.8 mmHg, p < 0.05). Throughout incremental exercise in hypoxia, SaO 2 was systematically higher after drug (peak exercise SaO 2 on Day 1: 71 ± 2 vs. Day 15: 81% ± 2%, p < 0.001), whereas oxygen extraction (Ca-vO 2 diff) and consumption (VO 2 ) were similar (peak exercise Ca-vO 2 diff on Day 1: 11.5 ± 1.7 vs. Day 15: 11.0 ± 1.8 ml/100 ml blood, p = 0.417; peak VO 2 on Day 1: 2.59 ± 0.39 vs. Day 15: 2.47 ± 0.43 l/min, p = 0.127). Throughout incremental exercise in normoxia, SaO 2 was systematically higher after drug, whereas peak VO 2 was reduced (peak exercise SaO 2 on Day 1: 93.9 ± 1.8 vs. Day 15: 95.8% ± 1.0%, p = 0.008; peak VO 2 on Day 1: 3.62 ± 0.55 vs. Day 15: 3.26 ± 52 l/min, p = 0.001). Conclusion: Pharmacologically increasing the affinity of Hb for oxygen improved SaO 2 during hypoxia without impacting exercise capacity; however, left shifting the ODC in healthy individuals appears detrimental to exercise capacity in normoxia. Left shifting the ODC to different magnitudes and under more chronic forms of hypoxia warrants further study.
Alterations in Nuclesome Core Particle Dynamics in the Context of Paraganglioma
Amato, Matthew , Maher, Louis Jim, Becker, Nicole A. , Zhao, Debiao Jim, Amato, Matthew, III, Louis James Maher , Botuyan, Maria Victoria

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 33 | Issue: S1 | Pages: No page available

10.1096/fasebj.2019.33.1_supplement.622.1 Get It

Paraganglioma (PGL) is a rare form of neuroendocrine cancer for which the underlying molecular basis is poorly understood. A mysterious hallmark of many PGL tumors is the inactivation of succinate dehydrogenase (SDH), a mitochondrial enzyme of the TCA cycle. Why does SDH loss induce cancer in certain cells? As a result of SDH loss, PGL tumor cells accumulate succinate, which may have epigenetic consequences. For example, certain lysine residues on histone proteins in nucleosomes are subject to succinylation by succinyl‐CoA as a post translational modification (PTM) that converts the lysine cation to an anion. We hypothesize that the structure and stability of the nucleosome core particle (NCP) is affected by succinylation PTMs through weakening of electrostatic histone‐DNA and histone‐histone interactions. Proteomic analysis of an SDH‐loss cell line model of PGL previously demonstrated that the greatest increase in nucleosomal lysine succinylation maps to H4K79 when compared to a control cell line. The mammalian H4K79 residue lies within the nucleosome core near wrapped DNA. We specifically hypothesize that the charge inversion conferred by H4K79 succinylation, destabilizes the NCP. Point mutations at H4K79 have been generated as lysine succinylation mimics at this site. Biophysical and in vitro transcription assays are being utilized to validate the assembly of NCPs incorporating lysine succinylation mimics at this site and to interrogate their resulting stabilities. Analyses of alterations in NCP dynamics in variant NCP will help to elucidate the role of lysine succinylation of histones in the altered chromatin landscape observed during PGL oncogenesis. Support or Funding Information GM75148‐09‐10 PREP This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Acute Pain Crisis Caused by Tramadol Remdesivir Drug–Drug Interaction
Teoli, Dac A., Thompson, Virginia H., Wright, Jessica , Ho, Ivana, Vlaminck, Brittany, Miller, G, Feely, Molly A., Teoli, Dac, Thompson, Virginia, Miller, Gina, Feely, Molly, Wright, Jessica A

Mayo Clinic

Journal of Palliative Medicine | June 21, 2021 | Volume: 24 | Issue: 10 | Pages: 1582-1584

10.1089/jpm.2021.0123 | PMID 34152842 Get It

Drug interactions are common and can affect patient outcomes. Drugs that undergo emergency approval have less preapproval drug testing to identify potential interactions. Tramadol is an effective pain medication prodrug with a complex mechanism of action that requires extensive metabolism. Remdesivir is an antiviral medication given emergency approval to treat hospitalized patients with COVID-19 infections. Remdesivir is also a nucleotide analogue prodrug that undergoes intracellular metabolic conversions to its active metabolite. We discuss the case of a hospitalized patient in the United States diagnosed with COVID-19 pneumonia who developed acute pain crisis secondary to a drug–drug interaction between tramadol and remdesivir, and we propose a possible mechanism of interaction.
Structural Basis for Improved Proteolytic Stability and Target Affinity of Disulfide engineered Human Kunitz‐type Serine Protease Inhibitors
Cohen, Itay , Shahar, Anat , Sankaran, Banumathi , Hockla, Alexandra , Papo, Niv , Coban, Matt , Caulfield, Thomas R. , Radisky, Evette S.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 33 | Issue: S1 | Pages: No page available

10.1096/fasebj.2019.33.1_supplement.472.1 Get It

Serine protease inhibitors of the Kunitz‐bovine pancreatic trypsin inhibitor (BPTI) family, such as tissue factor pathway inhibitor‐1 Kunitz domain 1 ( KD1 TFPI1) and amyloid precursor protein inhibitor (APPI), are biological regulators of proteolysis and serve as important scaffolds for developing therapeutics. Mesotrypsin is a unique human protease with cancer‐promoting properties which rapidly cleaves and inactivates serine protease inhibitors; because of this, it is a challenging therapeutic target and an excellent model for developing therapeutic inhibitors with improved proteolytic resistance. We hypothesize that stabilization of the Kunitz inhibitor binding loop by disulfide bond anchoring to the scaffold can reduce proteolytic susceptibility and improve binding efficacy. Here we have engineered a new disulfide bond into both KD1 TFPI1 and an APPI variant previously engineered for mesotrypsin affinity. The new disulfide bond anchors the binding loop to the scaffold, resulting in reduced mesotrypsin proteolytic cleavage by 17‐fold and 3‐fold, respectively. To gain insight into the structural basis for improved proteolytic stability, we crystallized mutant KD1 TFPI1 and APPI with mesotrypsin and solved these novel structures. We then performed all‐atom molecular dynamics simulations using these mesotrypsin‐mutant inhibitor complexes compared to models lacking the engineered disulfide bond. Our simulation results support our hypothesis that the cause of decreased proteolysis rates is dampened conformational fluctuations in the binding loop and minimized motion at the enzyme‐inhibitor interface. We also performed simulations using unbound inhibitors to show that stabilization of the binding loop to states similar to the bound configuration correlates with stronger binding affinity. Our disulfide engineering approach is potentially a useful tool in biopharmaceutical development for mesotrypsin, other serine proteases, and possibly for other enzyme targets. Support or Funding Information NIH grant R01CA154387 to E.S.R., European Research Council grant 336041 to N.P., US‐Israel Binational Science Foundation grant BSF2015134 to E.S.R. and N.P. Xray diffraction data were measured at the Berkeley Center for Structural Biology at the Advanced Light Source and at the European Synchrotron Radiation Facility. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
CYP2C9 and CYP2C19 : Massively Parallel Characterization of the Function of Genomic Missense Variants
Zhang, Lingxin , Sarangi, Vivekananda , Moon, Irene, Devarajan, Sandhya, Wang, Liewei , Weinshilboum, Richard, Zhang, Lingxin, Reid, Joel M.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 33 | Issue: S1 | Pages: No page available

10.1096/fasebj.2019.33.1_supplement.lb66 Get It

Single nucleotide variants in the open reading frames (ORFs) of pharmacogenes are important causes of interindividual variability in drug response. Because of the very large number of missense variants in ORFs, it is difficult to link the genotypes of these variants to their phenotypes using “one at a time” expression systems. Therefore, the functional characterization of variants of unknown significance in clinically important pharmacogenes remains a major challenge in pharmacogenomics. Deep mutational scanning (DMS) is a high‐throughput technique that make it possible to analyze hundreds of different missense variants in a parallel and scalable fashion. Engineered “landing pad” HEK 293T cells were used as a platform to integrate pooled variant libraries, resulting in one variant per cell for further assessment. We adapted this DMS system to analyze the function of missense variants in the ORFs of CYP2C9 and CYP2C19 . The ORFs of CYP2C9 and CYP2C19 were fused to green fluorescent protein, and individual variants with different fluorescence intensities were used to indicate different levels of protein expression. Pooled variant libraries were generated by nicking mutagenesis, and we then used recombinase to integrate the libraries into landing pad cells, one per cell. Multiplexed functional selection performed with Fluorescence Activated Cell Sorting separated cells into different bins by fluorescence readout at the single–cell level. Amplicon sequencing of DNA collected in each bin, followed by computational analysis of the frequency of variants appearing in each bin, was used to determine levels of protein expression. To identify potentially severely damaging variants for these two important pharmacogenes, we studied 243 missense variants in the CYP2C9 and CYP2C19 ORFs that had been identified by the Exome Aggregation Consortium Project and by the Mayo Clinic RIGHT 1K Study. We found that 13 of 115 CYP2C9 and 25 of 128 CYP2C19 missense variants displayed less than approximately 25% of the wildtype protein expression, a level that may have clinical relevance for drug metabolism. Variant calling by the DMS method for the severely damaging variants was compared with the results of individual variant assay by western blot and with the predictions of computational algorithms such as Polyphen and SIFT. Our results suggest that DMS is an efficient method for the high‐throughput identification of damaging ORF variants that might have potential clinical application in pharmacogenomics. Support or Funding Information Funded by NIH grant U19 GM61388 (The Pharmacogenomics Research Network), R01 GM28157, R01 GM125633, T32 GM08685 and by the Mayo Clinic Center for Individualized Medicine This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Sequential lipolysis and lipophagy pathways orchestrate lipid droplet breakdown in hepatocytes
Weller, Shaun G. , McNiven, Mark A. , Schott, Micah B. , Schulze, Ryan J.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 33 | Issue: S1 | Pages: No page available

10.1096/fasebj.2019.33.1_supplement.82.2 Get It

Neutral lipids are a critical source for cellular energy and are stored within specialized organelles known as lipid droplets (LD). Degradation of LDs for energy utilization is accomplished by two principal pathways: lipolysis that is activated by cAMP to recruit adipose triglyceride lipase (ATGL) to the LD surface, and lipophagy that utilizes the autophagic machinery to target and traffic LDs for degradation by lysosomal acid lipase (LAL). However, the mechanisms underlying synergy between these seemingly distinct pathways are not well understood. Previous studies show that autpohagic membrane cannot effectively engulf large organelles, but is size‐restricted to small cargo. Based on this, we HYPOTHESIZE that lipolysis and lipophagy are sequential pathways whereby lipolysis first reduces the size of large LDs to allow for subsequent autophagic engulfment of small LDs for lipophagy. Methods Using light and electron microscopy combined with biochemical approaches, we explored LD size and the sequential nature of lipolysis and lipophagy in primary rat and AML12 hepatocytes. Live‐cell microscopy was used for the first time to monitor LDs transitioning from lipolysis in the cytoplasm to lipophagy within endolysosomal vesicles. Results Confocal microscopy of endogenous ATGL revealed a preferential association with large LDs with an average size of 4.0 μm 2 , seven‐fold larger than LDs not associated with ATGL. In striking comparison, LDs associated with components of the autophagic machinery (LC3, Lamp3) were 50% smaller in size (0.39 μm 2 ). Consistent with this observation, siRNA knockdown of ATGL resulted in the persistence of large LDs (2.8 μm 2 ), whereas knockdown of LAL left cells filled with numerous small LDs (1.5 μm 2 ). These observations were mimicked by inhibitors of ATGL (atglistatin) and LAL (lalistat). In support of these findings, differential centrifugation of AML12 homogenates allowed for separation of two distinct populations of LDs: a buoyant fraction of large LDs enriched in the cytosolic lipase ATGL, and a second collection of smaller, less buoyant LDs enriched in lysosomal enzymes such as Lamp2A, the autophagosome marker LC3‐II, and the endosomal marker Tsg101. Most interesting are time lapse movies of live cells showing engulfment of small LDs by a Lamp3‐positive late endosomal compartment, suggesting that these organelles play an important role in the direct targeting and engulfment of LDs for lipophagy. Conclusion Hepatocytes appear to catabolize LDs in a tandem stepwise process that first utilizes cytosolic lipases to substantially reduce LD size, thereby allowing for subsequent engulfment of small LDs by autophagosomes as well as late endosomes and lysosomes. Support or Funding Information Supported by NIAAA RO1AA020735 to MAM; NIDDK award T32DK007352 to MBS and RJS, and the Mayo Clinic Kogod Aging Fellowship to MBS. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Effects of exercise on vasomotor function and vascular distensibility in angiotensin II‐induced hypertension
Thalji, Nassir M , Hagler, Michael A , Roos, Carolyn M, Pham, Duc, Smith, Leslie , Zhang, Bin , LeBrasseur, Nathan K. , Miller, Jordan D.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 29 | Issue: S1 | Pages: No page available

10.1096/fasebj.29.1_supplement.994.25 Get It

Activation of NADPH oxidase is a major contributor to hypertension, reactive oxygen species generation, endothelial dysfunction and increased vascular distensibility in angiotensin II (AngII)‐induced hypertension. Since exercise has been associated with increased antioxidant enzyme expression in blood vessels, we hypothesized that exercise training would improve endothelial function and vascular distensibility in mice with AngII‐induced hypertension. C57BL/6J mice received saline or AngII (1000 ng/kg/min) via osmotic minipumps, and were assigned to sedentary or treadmill exercise groups (13 m/min for 30 minutes, 5 days/week) for 14 days. Endothelium‐dependent relaxation in response to acetylcholine and arterial distensibility were assessed in carotid arteries using a pressurized arteriograph system. Gene expression was examined by qRT‐PCR. In AngII‐treated sedentary mice, endothelium‐dependent relaxation was impaired, while distensibility was higher than in saline‐infused sedentary mice. Compared to AngII‐infused sedentary mice, however, endothelium‐dependent relaxation was partially improved, and distensibility normalized in AngII‐infused exercised mice. In response to exercise, mRNA levels of SOD1 and SOD2 in aorta were increased, while mRNA levels of NOX2 were reduced. We conclude that exercise training can dramatically improve endothelial dysfunction and reverse derangements in carotid distensibility following prolonged AngII‐induced hypertension. Additional work examining mechanisms underlying our observed transcriptional changes will be critical to development of novel therapeutic targets.
Skeletal Muscle β‐F1‐ATPase Translation is Inhibited by Hyperlipidemia‐Induced miR‐127‐5p Expression in Human Obesity
Campbell, Latoya E., Mandarino, Lawrence J. , Tran, Lee, Coletta, Dawn K. , Katsanos, Christos S.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 29 | Issue: S1 | Pages: No page available

10.1096/fasebj.29.1_supplement.974.6 Get It

We recently discovered persistent downregulation of the H + ‐ATP synthase catalytic subunit (β‐F1‐ATPase) in skeletal muscle of obese individuals, which was linked to comorbid hyperlipidemia. β‐F1‐ATPase expression is primarily regulated post‐transcription, i.e. miRNAs, but the precise mechanism impeding expression are unclear. We tested the hypothesis that hyperlipidemia reduces β‐F1‐ATPase translational efficiency and is mediated by miR‐127‐5p, a miRNA known to control β‐F1‐ATPase translation. Biopsies isolated from the vastus lateralis of lean (BMI蠄25; n=7) and obese (BMI蠅30; n=6) subjects were evaluated for mRNA/miRNA expression via qRT‐PCR, protein by Western blot, and translation efficiency was calculated as the mRNA/protein ratio. Our results confirmed β‐F1‐ATPase translation was lower in obese individuals (P<0.01; 0.25±0.05%) compared to healthy weight controls (0.59±0.09%), and correlated with miR‐127‐5p expression (P<0.01; r=‐0.67). Bisulfite sequencing analysis of the miR‐127‐5p promoter revealed two hypomethylated sites in obese individuals, which may sustain an upregulation. Moreover, we found miR‐127‐5p present in muscle‐derived blood exosomes suggesting putative involvement in intracellular cross‐talk. In primary myotubes from a lean volunteer, prolonged fatty acid exposure increased miR‐127‐5p expression. Free Fatty Acid (mEq/L) Unsaturated/ Saturated mRNA (2 ‐ DD Ct ) Protein (AU) Translation (%) CTRL 0.347 ‐ 1.70±0.113 0.216±0.062 0.130±0.040 Lo Fat 0.185 0.55 1.60±0.094 0.202±0.038 0.123±0.008 Hi Fat 0.251 2.29 1.35±0.133* 0.095±0.006* 0.073±0.010 Hi Fat 0.269 0.54 1.66±0.145 0.093±0.003* 0.050±0.004* * P <0.05; One‐way ANOVA, Tukey9s posttest Inhibiting miR‐127‐5p with locked nucleic acids dose‐dependently improved β‐F1‐ATPase translation. Inhibitor (nM) mRNA (2 ‐ DD Ct ) Protein (AU) Translation (%) 0 1.84±0.314 0.22±0.062 0.647±0.120 10 1.93±0.387 1.24±0.135* 0.500±0.148 50 2.00±0.498 1.24±0.242** 1.483±0.233* 100 1.76±0.207 1.54±0.086* 0.892±0.096 * P <0.05; ** P <0.01; *** P <0.001; 1‐way ANOVA, Tukey9s posttest Our results provide evidence implicating hyperlipidemia‐induced miR‐127‐5p expression in suppressing β‐F1‐ATPase translation in human obesity. Funding from NIH/NIDDK grant DK094062 to CSK
Evaluating the Effectiveness of Pretest and Posttest Model of Active Learning in a Medical School
Mohanram, Arun Mehnaatamai, Singh, T. Jalal, Jagadeesh, Ashraya , Mohanram, Arun Mehnaatamai, Zhong, Qing, Singh, Tarun

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 29 | Issue: S1 | Pages: No page available

10.1096/fasebj.29.1_supplement.928.4 Get It

Effective medical education is extremely challenging in these times of high competitiveness. With the evolving curriculum changes and shorter contact hours, it is becoming extremely difficult to perform TBL sessions and Flipped Classroom sessions of active learning. In order to strike a balance between short contact hours and effective learning, we tried adding a Pretest and a Posttest to the traditional didactic lecture session. This method works on the principle that by including a multiple‐choice questions based Pretest and Posttest session before and after the didactic lecture respectively, the educator can heighten the attentiveness of the students and make them actively seek information during the lecture session. In order to test this hypothesis, we divided the pharmacology class into two groups namely Group A and Group B and conducted a cross‐over study. On Day 1, Group A was given a Pretest and a Posttest while Group B was given only a Posttest. On Day 2, Group A was given only a Posttest while Group B was given a Pretest and a Posttest. The tests were scored, totalled and compared. Analysis of the results showed that the groups that took both a Pretest and a Posttest significantly scored higher percentages and passing grades compared to the groups that took only the Posttest, albeit not statistically significant. This study clearly demonstrates the advantage of sensitizing the student's minds with a Pretest before the lecture begins. Based on the results of this study, by including a Pretest and a Posttest session to the routine didactic lecture, we can help students not only gain considerably from the lectures but also measure the same.
Hepatoma‐Derived Growth Factor (HDGF) Acts in Ovarian Cancer via Distinct Intracellular and Extracellular Mechanisms
Giri, Karuna, Prakash, YS, Pabelick, Christina M. , Mukherjee, Priyabrata

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 29 | Issue: S1 | Pages: No page available

10.1096/fasebj.29.1_supplement.726.6 Get It

Ovarian cancer is the eighth most common cancer and the fifth leading cause of cancer death among US women. Hepatoma‐derived growth factor (HDGF) is a heparin binding, secreted mitogen with prognostic value in multiple cancers. We previously reported that HDGF is overexpressed in ovarian cancer. Surprisingly, the mechanisms by which HDGF acts in any cell type remains to be fully elucidated. We hypothesized that overexpression of HDGF in ovarian cancer cells is functionally relevant and that HDGF confers pro‐survival and proliferative properties, promoting cancer growth. To elucidate intracellular and extracellular signaling mechanisms, we examined the effect of HDGF knockdown via siRNA, overexpression of HDGF and stimulation by full‐length recombinant protein. Immunofluorescence image analysis showed nuclear localization of HDGF in OV202 cell line. Additionally, HDGF was minimally secreted but passively released in greater amounts by necrotic cells. Extracellular HDGF stimulated phosphorylation of ERK and p38. In contrast, modulating intracellular HDGF did not affect MAPK pathways. In fact, intracellular HDGF functioned in a distinct manner by regulating cellular metabolism. This suggests that HDGF acts in ovarian cancer cells via two distinct mechanisms, both of which could be exploited for ovarian cancer therapy. Supported by the Mayo Graduate School (Giri) and the Department of Anesthesiology, Mayo Clinic (Prakash).